Capital International Investors Amgen Inc Transaction History

Capital International Investors

$483 Billion
Q1 2024

A detailed history of Capital International Investors transactions in Amgen Inc stock. As of the latest transaction made, Capital International Investors holds 7,005,269 shares of AMGN stock, worth $2.14 Billion. This represents 0.41% of its overall portfolio holdings.

Number of Shares

7,005,269

Previous 1,081,354 547.82%

Holding current value

$2.14 Billion

Previous $311 Million 539.5%

% of portfolio

0.41%

Previous 0.07%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $1.59 Billion - $1.92 Billion	5,923,915 Added 547.82%	7,005,269 $1.99 Billion
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $86.6 Million - $97.6 Million	338,515 Added 45.57%	1,081,354 $311 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $35.9 Million - $44.6 Million	164,374 Added 28.42%	742,839 $200 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $23,355 - $27,617	109 Added 0.02%	578,465 $128 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $41,093 - $50,086	182 Added 0.03%	578,356 $140 Million

Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $57,257 - $72,752	250 Added 0.04%	578,174 $152 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $16,610 - $18,733	74 Added 0.01%	577,924 $130 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $13.2 Million - $14.7 Million	-57,138 Reduced 9.0%	577,850 $141 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $429 Million - $474 Million	-1,954,872 Reduced 75.48%	634,988 $154 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $46,736 - $53,486	235 Added 0.01%	2,589,860 $583 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $91.4 Million - $107 Million	430,393 Added 19.93%	2,589,625 $551 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $44.3 Million - $49.2 Million	189,782 Added 9.64%	2,159,232 $526 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $82.4 Million - $96 Million	-371,136 Reduced 15.86%	1,969,450 $490 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $164 Million - $196 Million	-759,446 Reduced 24.5%	2,340,586 $538 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $237 Million - $264 Million	-1,010,388 Reduced 24.58%	3,100,032 $788 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $315 Million - $386 Million	-1,589,967 Reduced 27.89%	4,110,420 $969 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $170 Million - $226 Million	933,191 Added 19.58%	5,700,387 $1.16 Billion
Q4 2019 Feb 18, 2020	SELL	$189.21 - $243.2 $49.2 Million - $63.3 Million	-260,127 Reduced 5.17%	4,767,196 $1.15 Billion
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $692 Million - $829 Million	-3,972,062 Reduced 44.14%	5,027,323 $973 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $6.55 Million - $7.68 Million	39,282 Added 0.44%	8,999,385 $1.66 Billion
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $298 Million - $336 Million	-1,646,336 Reduced 15.52%	8,960,103 $1.7 Billion
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $86.8 Million - $101 Million	-486,743 Reduced 4.39%	10,606,439 $2.06 Billion
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $1.54 Billion - $1.74 Billion	8,329,861 Added 301.44%	11,093,182 $2.3 Billion
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $12,121 - $13,615	73 Added 0.0%	2,763,321 $510 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $14.1 Million - $16.5 Million	83,200 Added 3.1%	2,763,248 $471 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $448 Million - $512 Million	2,680,048	2,680,048 $500 Million

Others Institutions Holding AMGN

# of Institutions

2,929

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $164B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.

Account

Capital International Investors Amgen Inc Transaction History